TrialIndian journal of ophthalmology2014

A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension.

Navreet Kaur Natt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.